Trial intelligence / Profile preview

Genistein with Chemoradiation in Head and Neck Cancer

NCT02075112Phase 1Completed

Sponsor
Emory University
Start
Nov 2013
Primary completion
Sep 2019
Modality
Orthosteric Ligands
Countries
1
01

Overview

Phase 1, open-label, single-arm trial of genistein in xerostomia, sponsored by Emory University. Primary endpoint: Percentage of patients with grade 2 or higher xerostomia at 1 year. Started Nov 2013; status: completed.

02

Drugs

genistein
03

Conditions

xerostomia

Beyond the preview

Go deeper on NCT02075112.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02075112.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call